RespireRx Pharmaceuticals Inc (RSPI): From the Form 144 filed on June 2, it lo...

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	87
Posts	33385
Boards Moderated	87
Alias Born	03/22/2005

gfp927z

Re: None

Monday, 06/15/2015 11:38:21 AM

Monday, June 15, 2015 11:38:21 AM

From the Form 144 filed on June 2, it looks like Ayer Capital Management decided to exercise the convertible feature of their convertible note. Looks like they received just over 48 mil common shares in the conversion back in March, and then filed to sell 3.768 mil of those shares, to be sold between May 30 and Aug 30. The 3.768 mil shares represents 1% of the total 376.8 mil Cortex shares outstanding. The 3.768 mil shares to be sold are worth approx $113 K based on .03 cents/share -

http://www.sec.gov/Archives/edgar/data/849636/000114036115022830/form144.htm#F3

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent RSPI News

Form 8-K - Current report • Edgar (US Regulatory) • 09/06/2024 12:45:11 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/02/2024 12:30:23 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/08/2024 08:01:32 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/29/2024 01:03:20 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/02/2024 01:30:27 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/22/2024 01:45:38 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/11/2023 01:45:18 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/17/2023 09:06:03 PM
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/14/2023 09:05:14 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/12/2023 01:00:21 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/02/2023 12:45:26 PM